Order Article Reprints

Pizzimenti C, Fiorentino V, Ieni A, Rossi ED, Germanà E, Giovanella L, Lentini M, Alessi Y, Tuccari G, Campennì A, et al. BRAF-AXL-PD-L1 Signaling Axis as a Possible Biological Marker for RAI Treatment in the Thyroid Cancer ATA Intermediate Risk Category. International Journal of Molecular Sciences. 2023; 24(12):10024. https://doi.org/10.3390/ijms241210024

Pizzimenti, Cristina, Vincenzo Fiorentino, Antonio Ieni, Esther Diana Rossi, Emanuela Germanà, Luca Giovanella, Maria Lentini, Ylenia Alessi, Giovanni Tuccari, Alfredo Campennì, and et al. 2023. "BRAF-AXL-PD-L1 Signaling Axis as a Possible Biological Marker for RAI Treatment in the Thyroid Cancer ATA Intermediate Risk Category" International Journal of Molecular Sciences 24, no. 12: 10024. https://doi.org/10.3390/ijms241210024

Pizzimenti, C., Fiorentino, V., Ieni, A., Rossi, E. D., Germanà, E., Giovanella, L., Lentini, M., Alessi, Y., Tuccari, G., Campennì, A., Martini, M., & Fadda, G. (2023). BRAF-AXL-PD-L1 Signaling Axis as a Possible Biological Marker for RAI Treatment in the Thyroid Cancer ATA Intermediate Risk Category. International Journal of Molecular Sciences, 24(12), 10024. https://doi.org/10.3390/ijms241210024